WAY-261240
WAY-261240 is a synthetic compound that acts as a selective estrogen receptor modulator (SERM). It is primarily used in scientific research to study the effects of estrogen receptor activation and modulation in various biological systems.
Chemical Properties[edit]
WAY-261240 is characterized by its unique chemical structure, which allows it to selectively bind to estrogen receptors. The compound's molecular formula is C20H21NO3, and it has a molecular weight of 323.39 g/mol. The structure of WAY-261240 includes a core phenyl ring system with various functional groups that contribute to its binding affinity and selectivity.
Mechanism of Action[edit]
WAY-261240 functions by binding to estrogen receptors, which are nuclear hormone receptors that regulate gene expression in response to the hormone estrogen. As a SERM, WAY-261240 can act as an agonist or antagonist depending on the tissue type. This dual action is due to its ability to induce conformational changes in the estrogen receptor, influencing the recruitment of coactivators or corepressors.
Pharmacological Effects[edit]
In preclinical studies, WAY-261240 has been shown to exhibit tissue-selective effects. It can mimic the effects of estrogen in certain tissues, such as bone and the cardiovascular system, while blocking estrogenic effects in other tissues, such as the breast and uterus. This makes it a valuable tool for studying the differential effects of estrogen receptor activation.
Research Applications[edit]
WAY-261240 is used extensively in research to explore the role of estrogen receptors in various physiological and pathological processes. It is particularly useful in studies investigating the potential therapeutic applications of SERMs in conditions like osteoporosis, breast cancer, and cardiovascular disease.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of WAY-261240 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. Researchers handling WAY-261240 must adhere to safety protocols to minimize exposure and potential risks.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
